POMC Neurons in Hypothalamus
Overview
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">POMC Neurons in Hypothalamus</th>
</tr>
<tr>
<td class="label">Peptide</td>
<td>Sequence</td>
</tr>
<tr>
<td class="label">α-MSH</td>
<td>SYSMEHFRWGKPV</td>
</tr>
<tr>
<td class="label">β-Endorphin</td>
<td>YGGFMTPEKSQT</td>
</tr>
<tr>
<td class="label">ACTH</td>
<td>SYSMEHFRWGKPAKTL</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">MC4R</td>
<td>Agonists</td>
</tr>
<tr>
<td class="label">POMC processing</td>
<td>PCSK1 enhancers</td>
</tr>
<tr>
<td class="label">Leptin signaling</td>
<td>Sensitizers</td>
</tr>
<tr>
<td class="label">mTOR inhibition</td>
<td>Rapamycin</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[NPY/AgRP neurons](/cell-types/hypothalamic-npy-neurons)</td>
<td>Mutual inhibition</td>
</tr>
<tr>
<td class="label">[Leptin](/proteins/leptin-protein)</td>
<td>Leptin receptor signaling</td>
</tr>
<tr>
<td class="label">[Insulin](/proteins/insulin-protein)</td>
<td>Insulin receptor signaling</td>
</tr>
<tr>
<td class="label">[Neuroinflammation](/mechanisms/neuroinflammation)</td>
<td>Cytokine modulation</td>
</tr>
</table>
Pro-opiomelanocortin (POMC) neurons in the [hypothalamus](/brain-regions/hypothalamus) are a critical population of anorexigenic (appetite-suppressing) cells located primarily in the [arcuate nucleus](/brain-regions/hypothalamus) (ARC). These neurons produce POMC-derived peptides including α-melanocyte-stimulating hormone (α-MSH), β-endorphin, and adrenocorticotropic hormone (ACTH), which collectively regulate food intake, energy expenditure, stress responses, and pain modulation. The melanocortin pathway centered on POMC neuron signaling is one of the most important regulatory systems for body weight control, acting as the primary counterbalance to [NPY/AgRP orexigenic neurons](/cell-types/hypothalamic-npy-neurons).
POMC neurons function as key integrators of metabolic signals, receiving direct input from circulating [leptin](/proteins/leptin-protein) and [insulin](/proteins/insulin-protein), and responding by releasing peptides that suppress hunger and increase energy expenditure. Unlike the simple on/off switch of NPY/AgRP neurons, POMC neurons exhibit graded, activity-dependent peptide release that fine-tunes metabolic state.
Molecular Identity
POMC Processing
POMC is a 241-amino acid precursor protein that undergoes tissue-specific processing by prohormone convertases (PCSK1, PCSK2). In hypothalamic POMC neurons, the key products are:
The balance between α-MSH (agonist) and [AgRP](/genes/agrp) (inverse agonist) at MC3R/MC4R determines the net melanocortin tone — a key parameter for metabolic homeostasis.
Receptor Expression
POMC neurons express melanocortin receptors (primarily MC3R and MC4R) in an autocrine/paracrine manner, allowing α-MSH to regulate their own activity. They also express:
- Leptin receptor (LepRb) — for leptin's anorexigenic signal
- Insulin receptor (IR) — for insulin's satiety signal
- NPY Y1 receptor — allowing direct detection of NPY release from neighboring cells
- Glutamate receptors — for glutamatergic inputs from higher brain regions
Distribution
The primary POMC neuron population resides in the [arcuate nucleus](/brain-regions/hypothalamus) of the [hypothalamus](/brain-regions/hypothalamus). A smaller population exists in the nucleus tractus solitarius (NTS) of the brainstem, where they regulate nausea, satiety, and visceral responses. The POMC neurons in ARC and NTS arise from distinct embryological origins and have partially overlapping but distinct functions.
Electrophysiology
- Leptin activation: Leptin binding to LepRb activates JAK2-STAT3 signaling, which enhances POMC transcription and increases neuronal firing rate
- Insulin modulation: Insulin suppresses POMC activity through PI3K signaling, providing a meal-related brake
- Amino acid sensing: POMC neurons detect amino acid levels (particularly leucine) via mTOR signaling, linking protein intake to satiety
- Glucose sensing: POMC neurons are glucose-excited neurons, activated by high glucose levels to promote satiety
Role in Neurodegeneration
Alzheimer's Disease
[Alzheimer's disease](/diseases/alzheimers-disease) is associated with profound metabolic disturbances including anorexia, weight loss, and dysregulated energy expenditure. POMC neurons contribute to these phenotypes:
- Hypothalamic POMC dysfunction: Tau pathology in the [arcuate nucleus](/brain-regions/hypothalamus) directly affects POMC neurons, reducing their melanocortin output and contributing to the anorexia-cachexia syndrome observed in late-stage AD.
- Leptin resistance: AD patients show reduced leptin sensitivity in the hypothalamus, blunting the normal anorexigenic signal from POMC neurons.
- Metabolic dysfunction: POMC neuron deficiency in AD models leads to severe metabolic dysregulation, including impaired glucose tolerance and increased adiposity — paradoxically opposite to the weight loss seen in human AD, suggesting compensatory mechanisms in human disease.
- Sleep-wake disruption: POMC neurons modulate arousal states through projections to the paraventricular hypothalamus and lateral hypothalamus, and their dysfunction may contribute to circadian disruption in AD.
Parkinson's Disease
[Parkinson's disease](/diseases/parkinsons-disease) patients commonly experience weight loss, gastrointestinal dysfunction, and metabolic changes that precede motor symptoms. POMC neurons are implicated:
- Dopaminergic modulation: Dopamine from the mesocortical pathway normally modulates POMC neuron activity. In PD, this modulation is disrupted, altering the melanocortin axis.
- Alpha-synuclein pathology: Lewy pathology in the [hypothalamus](/brain-regions/hypothalamus) can affect POMC neurons and their projections to autonomic control centers, contributing to metabolic dysregulation.
- Neuroinflammation: Pro-inflammatory cytokines (IL-1β, TNF-α) suppress POMC neuron activity, contributing to the metabolic changes seen in PD.
- Gut-brain axis: The gastrointestinal pathology of PD (α-synuclein in the enteric nervous system) disrupts ghrelin signaling, which indirectly affects the melanocortin axis through cross-talk with POMC neurons.
Amyotrophic Lateral Sclerosis
[ALS](/diseases/amyotrophic-lateral-sclerosis) patients frequently develop hypermetabolism and weight loss despite adequate caloric intake. POMC neurons may contribute through autonomic and metabolic dysregulation, though the primary driver of metabolic changes in ALS is thought to be the motor neuron degeneration itself driving systemic catabolism.
Therapeutic Implications
MC4R agonists (setmelanotide) have shown efficacy in rare genetic obesity syndromes and are being explored for metabolic dysfunction in neurodegeneration. However, the complexity of the melanocortin axis means that systemic agonism can produce unwanted effects on sexual function, blood pressure, and bone metabolism.
Key Interactions
Open Questions
Can restoring POMC neuron function improve metabolic outcomes in AD/PD without producing unacceptable side effects?
What is the relative contribution of POMC vs NPY/AgRP neuron dysfunction to the anorexia-cachexia syndrome?
Does the melanocortin axis represent a druggable target for non-motor symptoms of PD (appetite, GI function)?
How does hypothalamic tau/α-synuclein pathology specifically affect POMC vs NPY/AgRP populations?